Philadelphia Positive (Ph+) Chronic Myeloid Leukemia
1 clinical trials · Condition
◉ Watch Philadelphia Positive (Ph+) Chronic Myeloid Leukemia
| Record | Firm | Date |
|---|---|---|
| Trial to Evaluate the Improvement of Chronic Low-grade AEs in Patients With Ph+ CML With Optimal Response to Imatinib When Switched to Nilotinib (NCT02115386) | Novartis Pharmaceuticals | 2015-12-17 |
Track Philadelphia Positive (Ph+) Chronic Myeloid Leukemia automatically
Every clearance here is in the API, with alerts when new ones post.